Abstract

Squamous cell carcinoma (SCC) is histologically the most prominent type of cervical cancer. There is accumulating evidence suggesting that microRNAs (miRNAs) play important regulatory roles in the biological processes of cervical squamous cell carcinoma (CSCC). Deciphering the miRNA regulatory network in CSCC could deepen our understanding at the molecular level of CSCC initiation and progression. In the present study, we performed next‑generation sequencing (NGS) to profile miRNA expression in 3pairs of early-stage CSCC samples. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to verify primary findings in another 20pairs of CSCC samples. We identified 37known miRNAs that exhibited significant alterations in expression (2-fold change or greater), among which 8miRNAs were upregulated and 29miRNAs were downregulated. Nine of these miRNAs were selected for further qRT-PCR validation. A novel miRNA candidate was also reported for the first time in the present study to be upregulated. The Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed that its target genes were involved in MAPK, calcium and adherent junction signaling pathways. The present study systematically characterized the miRNA expression variation in early-stage CSCC and provides novel biomarkers for diagnosis and treatment as well as an opportunity for further investigation of the molecular mechanisms underlying the pathogenesis and development of CSCC.

Highlights

  • IntroductionCervical cancer is the second most common cancer and the third leading cause of cancer-related

  • In less developed countries, cervical cancer is the second most common cancer and the third leading cause of cancer-relatedKey words: microRNA, cervical cancer, squamous cell carcinoma, early-stage, next-generation sequencing deaths in females

  • cervical squamous cell carcinoma (CSCC) caused by human papillomavirus (HPV) infection can be prevented, it is still a common cancer in women

Read more

Summary

Introduction

Cervical cancer is the second most common cancer and the third leading cause of cancer-related. The high cost is a major barrier to making screening and vaccination widely available to all women in developing countries, including China

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.